Patent · US Active

Polysubstituted 1,1-pyridylaminocyclopropanamine compounds

US7388022B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2006
Grant dateJun 17, 2008
Priority date
Expiry dateJul 26, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound selected from those of formula (I):wherein: Medicinal products containing the same which are useful in the treatment of conditions requiring a specific nicotinic ligand of α4β2 receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.